Pembrolizumab vs Ipilimumab - What's the difference?
pembrolizumab | ipilimumab |
A drug that targets the programmed cell death 1 (PD-1) receptor, intended for use in treating metastatic melanoma.
A human monoclonal antibody being developed as a drug to activate the immune system.
